Showing results (1-10 of 253) with videos related to
Sort By:
Pageof 26
Regulatory Peptides|May 5, 1994
Immunity to T cell receptor peptides: theory and applicationsH Offner, G A Hashim, A A VandenbarkJournal of Neuroscience Research|February 15, 1996
T cell receptor peptides in treatment of autoimmune disease: rationale and potentialA A Vandenbark, G A Hashim, H OffnerScience (New York, N.Y.)|January 25, 1991
T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitisH Offner, G A Hashim, A A VandenbarkJournal of Neuroscience Research|January 15, 1996
Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat V beta 8.2 sequence include CDR2 and framework 3 idiotopesM Vainiene, B Celnik, A A Vandenbark, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1994
Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptidesA A Vandenbark, M Vainiene, B Celnik, et al.International Reviews of Immunology|December 30, 1999
T cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP-specific clonesH Offner, A A VandenbarkJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Encephalitogenic T cell clones with variant receptor specificityH Offner, G A Hashim, Y K Chou, et al.Journal of Neuroscience Research|March 1, 1992
Common sequence on distinct V beta genes defines a protective idiotope in experimental encephalomyelitisM Vainiene, D P Gold, B Celnik, et al.Cellular Immunology|October 1, 1985
Gangliosides inhibit phenotypic and functional properties of an encephalitogenic T-helper lymphocyte lineH Offner, A A VandenbarkClinical and Experimental Rheumatology|March 1, 1993
T-cell receptor peptide therapy in EAE and MSA A Vandenbark, D N Bourdette, R Whitham, et al.Pageof 26